Marijuana Packaging

SEPTEMBER 23, 2024

The data showed a 25% drop in deaths from prescription medication between 1999 and 2010 throughout the 13 states that had opted to legalize marijuana. The co-author of this eye-opening study, Colleen Barry, pointed out that it is highly unlikely (if not outright impossible) for a human to consume a fatal amount of marijuana.

Marijuana 52

Marijuana Research and Development Data Legalization 52

Cannabis Law Report

MAY 26, 2022

In a more current report from Colorado from the Rocky Mountain HIDTA Training and Information Center (2020), it was reported that since recreational marijuana was legalized in 2013, past month youth (ages 12–17) marijuana use decreased 25% yet is 43% higher than the national average, currently ranked 7th in the nation. 2012, Calabria et al.,

Dispensary 52

Dispensary Research and Development Safety Recreational 52

Veriheal

SEPTEMBER 14, 2021

While the pool of study subjects could have been larger, researchers were satisfied with the data they gathered from 3,119 respondents. All respondents identified as American military veterans, and the information was pulled from a 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions–III (NESARC-III). .

Consumption 98

Consumption Research and Development Treatment Programs 98

Veriheal

DECEMBER 24, 2021

One of the original authors of the Compassionate Use of Medical Cannabis Pilot Program Act in 2013 (MCPP) — a law that led to the legalization of pharmaceutical-grade cannabis across the state of Illinois — says that growing demand and acceptance of the federally illegal plant has not reduced the risk of job loss.

Legislation 98

Legislation Recreational Patients Cannabis 98

The Cannigma

OCTOBER 9, 2021

The overall effects appear to be a reduction in inflammation, sensory activity and bladder contractility, resulting in prolonged bladder emptying of varied significance (Hedlund, 2013). According to the National Association of Incontinence, approximately 25 million Americans are suffering from episodes of involuntary loss of urine.

Cannabinoids 90

Cannabinoids Consumption Patients Cannabis 90

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Charlotte’s story was featured on CNN in 2013 and millions of people saw with their own eyes how a few drops of cannabis oil succeeded where no other epilepsy treatment had —- reducing her seizures from 300 each week to less than three a month.

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Joint Blog

FEBRUARY 13, 2020

We think there is a lot of overlap between conditions for which medical marijuana can be used in managing symptoms and the types of illnesses that lead people to file workers’ compensation claims,” said study coauthor, Catherine Maclean, an associate professor in the economics department at Temple University in Philadelphia.

Access 32

Access Marijuana Data Policy 32

The Joint Blog

DECEMBER 18, 2019

– Colorado county-level data show OTC sleep aid sales decline with recreational cannabis access, especially for diphenhydramine and doxylamine. . These findings support survey evidence that many individuals use cannabis to treat insomnia, although sleep disturbances are not a specific qualifying condition under any U.S.

Sleep 49

Sleep Legalization Marijuana Recreational 49

Otherside Farms

JULY 4, 2022

In treating depression and anxiety, CBG and CBC may be more effective than CBD and THC, but further research is needed to back up the growing body of anecdotal data. Has the Potential to Improve Neurological Condition. Pain and Inflammation. CBC has to get shown to be effective in the management of pain.

Research and Development 96

Research and Development Cannabinoids THC Concentrates 96

The Cannigma

MARCH 29, 2021

A 2013 comprehensive published in Frontiers in Psychology looked at CBD’s ability to offset the “adverse psychological effects of THC,” and concluded that “the few studies that exist on the effects of CBD show that this cannabinoid can counteract some of the negative effects of THC.”. Cardiac-related mortality data from the U.S.

Blood Pressure 144

Blood Pressure Indica THC Strains 144

Cannabis Cheri

NOVEMBER 27, 2018

Applied topically, cannabis can bring relief to a host of issues including aches and pains, inflammation, itching, rashes, skin conditions like acne, eczema, and psoriasis, skin cancers, and much more. We currently have little data and science to go on as to optimal topical dosages.

Topical 188

Topical Oil Marijuana THC 188

CannaTech

OCTOBER 14, 2018

The state was well-positioned to permit this type of farming back in 2013 when Senate Bill 566 was enacted, conditionally approving an industrial hemp pilot program. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. In the U.S. The approval of SB 1409 should help steer the remaining U.S.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Cannabis Law Report

JANUARY 9, 2019

Phoenix, headquartered in Denver, distributes medicinal cannabis products around the globe to treat seven major categories of medical conditions including pain, cancer, autoimmune, metabolic, neurological, psychological and sleep disorders. The biggest pushback Phoenix has received until now has been the lack of data, Tindall said.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Healer

JANUARY 17, 2022

People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. People who find CBD and/or CBDA too mentally stimulating. CBG vs. CBD.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development CBD 52

Healer

JANUARY 17, 2022

People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. People who find CBD and/or CBDA too mentally stimulating. CBG vs. CBD.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Canna Care Docs

JULY 29, 2019

She said it “just barely covers the pain” of her condition. A recently released study out of New York University, supported by the National Institute on Drug Abuse, looked at data from the National Survey on Drug Use and Health, an annual survey of 70,000 Americans of all ages. Around Christmastime last year, Ms.

Chronic Pain 53

Chronic Pain Sleep Education Dispensary 53

The Cannigma

DECEMBER 1, 2021

In a 2013 book, Marijuana is Safer: So Why Are We Driving People to Drink? Many cannabis skeptics are often surprised to learn that cannabis can represent an effective medicine for diverse conditions and disorders. Your parents may even find that cannabis could help with conditions that affect them.

Research and Development 104

Research and Development Tincture THC Cannabinoids 104

Cannabis Cheri

NOVEMBER 27, 2018

Applied topically, cannabis can bring relief to a host of issues including aches and pains, inflammation, itching, rashes, skin conditions like acne, eczema, and psoriasis, skin cancers, and much more. We currently have little data and science to go on as to optimal topical dosages.

Topical 100

Topical Oil Marijuana THC 100

StrainConnect

MARCH 9, 2019

In 2004, Dr. Ethan Russo developed the theory that this deficiency might explain the development of certain conditions, such as migraines, irritable bowel syndrome, or fibromyalgia(16). Of course, there is much more to discover, but Dr. Russo´s theory has opened the door to research methods to prevent and manage certain conditions.

Research and Development 42

Research and Development Cannabinoids Sativa CBD 42

Healer

APRIL 5, 2021

While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak. 2013): 685-692. [14]

CBD 98

CBD Chronic Pain Oil Topical 98

Cannabis Law Report

JANUARY 20, 2022

Founded in 2013, Eleusis is dedicated to transforming psychedelics into medicines. The transaction is expected to close in the second or third quarter of 2022, subject to customary closing conditions, including the receipt of regulatory approvals and approval by SPKB’s shareholders. About Eleusis.

Therapy 52

Therapy Research and Development Business Access 52

Medicinal Genomics

NOVEMBER 12, 2024

Many people claim to have Type II plants still alive today that predate the 2013 filing of the patent. By placing the sequence of a Type II plant public, we can help enable the community to sequence their documented Pre-2013 Type II plants. 2)The plant should have a history that predates 2013.

Hash 52

Hash Terpenes Data Extraction 52

Healer

APRIL 5, 2021

While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak. 2013): 685-692. [14]

CBD 52

CBD Chronic Pain Oil Topical 52

Healer

APRIL 5, 2021

While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak. 2013): 685-692. [14]

CBD 52

CBD Chronic Pain Oil Topical 52

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. Also, since 2013, there has been an increase in the number of publications focusing on children and the elderly.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Green Relief

MAY 13, 2018

These plant cannabinoids were also deemed useful for treating other neurodegenerative conditions, “such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”. In 2013, the International Journal of Molecular Science reported on how TBI is affected by diurnal variations of the endocannabinoid system. CBD for CTE.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

JULY 12, 2019

More research is needed to determine proper ratios for specific conditions, as well as genetic testing developed to determine appropriate course of treatment. Regarding the warning for specific populations that based on animal data the pharmaceutical may cause fetal harm. 2013 Sep;36(9):2530-5. TIEMANN, MPH, MS, RD BRUCE W.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Greencamp

SEPTEMBER 12, 2018

In a 2013 study, it was noted that the endocannabinoid system , and particularly its CB2 receptor, has potential therapeutic properties for managing autism. In a 2015 statement, the Canadian Pediatric Society said that “there is little data to support either the efficacy or safety of cannabis use for any indications in children.”.

Strains 76

Strains Research and Development Marijuana Therapy 76

Green Relief

MAY 12, 2018

These plant cannabinoids were also deemed useful for treating other neurodegenerative conditions, “such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”. In 2013, the International Journal of Molecular Science reported on how TBI is affected by diurnal variations of the endocannabinoid system. CBD for CTE.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

SMPL

MAY 26, 2020

And though a few outliers responded well to CBD alone, GW’s data showed that for relieving pain and inflammation, helping with sleep and alleviating seizures and spasms, most patients got the most benefit from an equal mix of CBD and THC — a drug the company called Sativex. A few months later, the network of early CBD advocates met up at Ms.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

StrainConnect

FEBRUARY 8, 2019

In 2013, it was found that CBD possesses [healing] properties. Consult with a physician before use if you have a serious medical condition or use prescription medications. Privacy Policy and all Terms & Conditions printed on this site. Dont modify these 3 pswp__item elements, data is added later on. -->. Share by:

Hemp 57

Hemp CBD Cannabinoids Sativa 57

Healer

JUNE 28, 2019

Cannabinoids have neuroprotective effects, protecting the nerves from acute injuries like head trauma and stroke, and from conditions that cause chronic injury, such as Alzheimer’s disease. OBJECTIVE: To determine the efficacy of medical marijuana in several neurologic conditions. ’ Koppel, Barbara S., Abstract: Medical Study .

Cannabinoids 52

Cannabinoids THC Therapy Patients 52

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

SEPTEMBER 14, 2021

WHEREAS, in 2013, simple cannabis possession was the fourth most common cause of deportation for any offense and the most common cause of deportation for drug law violations; and. WHEREAS, in 2018, the ACLU found that extreme racial disparities in cannabis possession arrests persists throughout the country, with the cannabis arrest rate 3.64

Policy 98

Policy Research and Development Access Cannabis 98

Cannabis Law Report

MARCH 29, 2020

triggering new innovations and improved data quality through better user experiences. o Medical conditions: A panel of doctors must be present at the time of any product research to ensure no adverse effects lessen or damage the health of participants.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

FEBRUARY 22, 2019

The initial phase of this activity is aimed at determining and selecting three of more varieties of hybridized hemp strains identified by InPlanta for testing in the specific ecological conditions found in Cambodia. This phase is underway and will be completed before the end of February.

Hemp 40

Hemp Research and Development Hybrid Environment 40